Multicenter Validation of the Salivary miRNA Signature of Endometriosis

Active, not recruitingOBSERVATIONAL
Enrollment

1,140

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

January 6, 2023

Study Completion Date

April 30, 2024

Conditions
Endometriosis
Trial Locations (18)

14000

CHU de Caen, Caen

20600

CH Bastia, Bastia

31059

CHU Toulouse - Hôpital Rangueil, Toulouse

31300

Clinique Pasteur, Toulouse

33000

Clinique Tivoli, Bordeaux

35000

Clinique La Sagesse, Rennes

CHU Rennes, Rennes

49933

CHU Angers, Angers

67200

CHU Strasbourg - Hôpital Hautepierre, Strasbourg

69000

HCL, Lyon

69002

Cabinet de Gynécologie Médicale, Lyon

75014

Groupe Hospitalier Saint Josef, Paris

75019

Centre d'imagerie Manin Crimée, Paris

75020

CHU Tenons, Paris

76230

CHU Rouen, Bois-Guillaume

78310

Centre médical des Pyramides, Maurepas

94275

Hôpital BICETRE, Le Kremlin-Bicêtre

Unknown

CHU Québec, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Monitoring Force Group

INDUSTRY

collaborator

iGenSeq

UNKNOWN

lead

ZIWIG

INDUSTRY

NCT05244668 - Multicenter Validation of the Salivary miRNA Signature of Endometriosis | Biotech Hunter | Biotech Hunter